HW
RVLP

Hancock Whitney’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Hancock Whitney’s Portfolio RVLP Stock Details RVLP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-53,724
Closed -$162K – 829
2021
Q2 		$162K Buy
53,724
+35,255
+191% +$108K 0.01% 781
2021
Q1 		$60K Hold
18,469
– – ﹤0.01% 771
2020
Q4 		$76K Hold
18,469
– – ﹤0.01% 778
2020
Q3 		$100K Sell
18,469
-4,000
-18% -$23K ﹤0.01% 758
2020
Q2 		$151K Buy
+22,469
New +$110K 0.01% 728
2019
Q2 		– Sell
-23,104
Closed -$83K – 882
2019
Q1 		$83K Buy
+23,104
New +$170K ﹤0.01% 817

Other funds holding RVLP

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RA
Rovida Advisors Fort Lauderdale, Florida $116M AUM 12.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Hancock Whitney's RVLP Position: Q3 2021 in Review

Hancock Whitney sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q3 2021, closing a stake of 53,724 shares — an estimated $162K sold.

Hancock Whitney first reported a position in RVLP in Q1 2019 and held it in 6 quarters. The position peaked at $162K in Q2 2021. 35 funds tracked by Wall St. Rank hold RVLP as of Q3 2021.

  • Hancock Whitney reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q3 2021 after selling out during the quarter.
  • Hancock Whitney sold 53,724 RVL Pharmaceuticals plc Ordinary Shares shares in Q3 2021, an estimated $162K.
  • Hancock Whitney first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q1 2019 and held it in 6 quarters.
  • Hancock Whitney's RVL Pharmaceuticals plc Ordinary Shares position peaked at $162K in Q2 2021.
  • 35 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q3 2021.

Based on Hancock Whitney's 13F filing for Q3 2021, filed 4 Nov 2021.